In the fall of last year, Amazon launched online pharmaceutical services, Amazon Pharmacy. According to the Amazon Pharmacy website, the services are available for customers over the age of 18. The customer has to create a separate account for Amazon Pharmacy. It should be noted that Prime savings can be applied at Amazon Pharmacy as well.
Tag: Pfizer

Israel Begins Coronavirus Vaccination
On Saturday night immediately after the first Saturday following the holiday of Hanukah Israel began vaccination of its people using Pfizer vaccine. The first to vaccinate was Prime Minister Netanyahu at the Sheba Medical Center Israel’ largest medical center in Tel Aviv. Joining Netanyahu to vaccinate was Yudi Edelstein the Minister of Health.

Coronavirus — Vaccines in Contrast
The Coronavirus pandemic continues to have an impact around the globe. Currently, there are over 75 million infected and 1.6 million deaths around the world. The are multiple vaccines against the Coronavirus. Russia was the first to release the Sputnik V vaccine. However, many were skeptical due to the fact that Phase 3 trials were not completed.

Coronavirus — Moderna Vaccine Close to Approval
Experts from the US Food and Drug Administration (FDA) announced on Tuesday, that the Moderna vaccine is safe and effective by 94 percent, which paves the way for approval for its use in emergency situations. The announcement means that Moderna may be the second Coronavirus vaccine permitted for use in the United States.

Coronavirus — US to Begin Distributing Vaccines
The United States began shipping the first batch of COVID-19 vaccines to all states in the United States at low temperatures from December 13, and is expected to be distributed to 636 distribution centers across the United States before the 16th. Pfizer and BioNTech have obtained emergency authorization from the US Food and Drug Administration for the vaccine.

U.S. Launches Largest Vaccine Distribution Plan in History
On Friday evening local time in the United States, the FDA approved Pfizer and BioNTech’s emergency use as new coronavirus vaccine, becoming the second country after the UK to approve the vaccine. The U.S. Centers for Disease Control and Prevention (CDC) immunization advisory committee then voted to recommend vaccination.

Coronavirus — UK Approves Pfizer-BioNtech Vaccine
British regulators have approved the COVID-19 vaccine developed by US company Pfizer and its German partner BioNtech for use in the UK. With the approval of the Medical and Health Products Regulatory Agency (MHRA), the United Kingdom becomes the first country in the world to start vaccinating its citizens against the coronavirus.

Libor Gets Stay of Execution, Overseas Market Heating Up
The Intercontinental Exchange Benchmark Management Agency may extend the three-month U.S. dollar Libor withdrawal deadline by one and a half years (previously the expected withdrawal date was the end of 2021). The six-month and 12-month U.S. dollar Libor deadline may also be postponed.

UK Set to Approve Pfizer, BioNTech’s Covid-19 Vaccine in Few Days
The UK will become the first Western country to approve the new coronavirus pneumonia vaccine, and independent regulatory agencies will approve it within a few days. According to insiders in the British government, the vaccine developed by BioNTech and Pfizer will begin delivery within hours of approval.

UK to Roll Out Vaccines Next Month
British Health Secretary Matt Hancock said that the United Kingdom plans to launch two new coronavirus vaccines next month. Then, the advancement of the vaccine plan will speed up after entering the new year. From there, the situation will gradually return to “normal” from the spring.

EU: UK Hasn’t Compromised Enough for Brexit Deal
The European Union warned that the UK has not taken enough action to overcome the three major obstacles facing a post-Brexit trade agreement. The leaders of Belgium, France, and the Netherlands urged greater efforts to prepare contingency plans in case an agreement is not reached.

EU Warns Against No-Deal Brexit, Rumored to Buy Vaccine
The leaders of France and Belgium urged the EU to intensify its efforts to prepare for a no-deal Brexit by the end of the year, in case negotiations with the UK fail to achieve a breakthrough at the last minute. That’s according to two people familiar with the relevant discussions at the EU leaders video summit on Thursday.

U.S. Stocks Collectively Opened Higher
In US stock market news from the financial world on Monday, investors are concerned about the impact of the economic reopening and the progress of the U.S. election. At the same time, positive vaccine news has once again boosted the market. US stocks opened collectively higher.

US Elections- Is The Reality Finally Dawning on Trump?
Donald Trump no longer seems so steely that he can retain the presidency of the United States. In his first speech since last weekend, which was held late Friday at the White House in Washington, he is quoted as having said that only “time will tell” who will be president of the United States.

Wyoming Reports 12 More COVID-19 Deaths
According to a recent article from the Cheyenne Post, the Wyoming Department of Health (WDH) has confirmed twelve new deaths related to the COVID-19 pandemic. The deaths, according to the Post, were mostly “older” adults from various parts of the state. All twelve deceased Wyoming citizens tested positive for COVID-19.

EU: New Vaccine to be Distributed Fairly
The European Union has reached a 300 million dose vaccine supply agreement with biotech companies, Biontech and Pfizer. Biontech emphasized that vaccines will be distributed fairly. At the same time, Germany is considering how to specifically implement the new coronavirus vaccine.

Biden Win, Vaccine News, Send Stocks Soaring
On Monday, investors paid attention to Fed officials’ speeches and economic data. At the same time, Democratic presidential candidate Joe Biden announced his victory, and the news that Pfizer claimed that its vaccine can prevent 90% of new coronavirus infections gave the market a strong boost.

Possible Vaccine a Shot in the Arm to Markets
The European stock market jumped to an eight-month high today after Pfizer and Biontech announced strong progress in their vaccine against COVID-19. Meanwhile, Democratic presidential candidate Joe Biden’s victory in the US presidential election raised hopes for a more stable trade policy for the United States.

Coronavirus Vaccine Enters Critical Phase
German biotechnology company BioNTech and the American pharmaceutical company, Pfizer, have announced the start of a very important global study to evaluate their top-ranked vaccine among potential vaccines for the COVID-19 disease. Both hope the study will be successful.

Projections for the Asthma Treatment market after COVID-19
Asthma is a chronic inflammatory lung disease. Asthma affects persons of all ages, but mostly starts in childhood. Asthma creates inflammation in the inside walls of airways which makes airways very sensitive to an allergic reaction. Asthma may be caused due to genetic, environmental factors or a combination of both.

Erythropoietin Drugs Market Sees Steady Growth
Erythropoietin drugs are also known as hematopoietin, which controls erythropoiesis as well as production of red blood cells. They are used to treat various diseases like cancer, chronic renal diseases, AIDS, anemia and other ailments.

Autoimmune Disease Drugs Market has a Solid Future
Autoimmune disease is a chronic health condition caused when the immune system starts attacking its own body’s cells. The Centers for Disease Prevention and Control reports around 22.7% or 54.4 million adults in America had doctor-diagnosed arthritis as per the National Health Interview Survey 2013-2015, with a higher prevalence in women (23.5%) than in men (18.1%).

UTI (Urinary Tract Infection) Treatment Market to See Small Results
The increasing prevalence of urinary tract infection (UTI) and growth in the number of prescriptions of quinolones antibiotics is expected to fuel the growth of the urinary tract infection treatment market. According to a new study published by Future Market Insights (FMI), the global urinary tract infection treatment market revenues will grow at a mere 2% CAGR between 2019 and 2029.

Cardiovascular Drugs Market Keeps the Beat
Cardiovascular disorders or heart disorders are disorders of circulatory systems and heart. Inflammatory heart disease, hypertensive heart disease, cerebrovascular heart disease, rheumatic heart disease, and ischemic heart disease fall under the commonly diagnosed cardiovascular disorders.

Human Insulin Market Delivering in New Ways
The global human insulin market is predicted to garner a CAGR of 12.1% during the forecast period (2017-2023), Market Research Future (MRFR) reveals in the latest report. Human insulin can be defined as a synthetic, which is largely manufactured in laboratories by developing insulin protein with E. coli bacteria.